← Back to Search

Behavioural Intervention

Enhanced Assistance During Radiotherapy for Cancer (EARN Trial)

N/A
Waitlist Available
Led By Joanna Yang, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Planned to receive or currently receiving a protracted course of curative-intent radiotherapy with specific fraction requirements
Must not have
Undergoing treatment for anaplastic thyroid cancer
Planned or scheduled to undergo radiotherapy simulation more than 28 days from the date of consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of radiotherapy (estimated to be 4 months)
Awards & highlights

Summary

This trial is studying a new program to help patients with unmet needs who are receiving more than 10 radiation therapy sessions. They want to see if this program can help patients finish their treatment on time

Who is the study for?
This trial is for patients with various cancers, including uterine, salivary gland, head and neck, vaginal, esophageal, stomach, bladder, cervical cancer and more. Participants must be undergoing radiotherapy in over 10 sessions.
What is being tested?
The study tests if enhanced assistance during radiotherapy helps patients complete their treatment without delays compared to past data on standard support.
What are the potential side effects?
Since the trial compares different levels of assistance rather than medications or treatments directly affecting health conditions there are no direct side effects from interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am undergoing or scheduled for a specific long-term radiation therapy aimed at curing my condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently being treated for anaplastic thyroid cancer.
Select...
My radiotherapy simulation is scheduled for more than 28 days after I give consent.
Select...
I am in the hospital and will not have more than 10 radiotherapy sessions as an outpatient.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of radiotherapy (estimated to be 4 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of radiotherapy (estimated to be 4 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Delay-free completion of radiotherapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Standard Assistance + Enhanced AssistanceExperimental Treatment2 Interventions
In the time period that patients are receiving radiotherapy, study participants will receive standard plus enhanced financial assistance for unmet essential needs.

Find a Location

Who is running the clinical trial?

American Society of Clinical OncologyOTHER
37 Previous Clinical Trials
148,116 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,970 Previous Clinical Trials
2,308,590 Total Patients Enrolled
Joanna Yang, M.D.Principal InvestigatorWashington University School of Medicine
~22 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top